| [1] |
Lacombe V, Lenaers G, Urbanski G. Diagnostic and therapeutic perspectives associated to cobalamin-dependent metabolism and transcobalamins’ synthesis in solid cancers[J]. Nutrients, 2022, 14(10): 2058.
|
| [2] |
Johnston J, Bollekens J, Allen RH, et al. Structure of the cDNA encoding transcobalamin Ⅰ, a neutrophil granule protein[J]. J Biol Chem, 1989, 264(27): 15754-15757.
|
| [3] |
Liu GJ, Wang YJ, Yue M, et al. High expression of TCN1 is a negative prognostic biomarker and can predict neoadjuvant chemosensitivity of colon cancer[J]. Sci Rep, 2020, 10(1): 11951.
|
| [4] |
Johnston J, Yang-Feng T, Berliner N. Genomic structure and mapping of the chromosomal gene for transcobalaminⅠ (TCN1): comparison to human intrinsic factor[J]. Genomics, 1992, 12(3): 459-464.
|
| [5] |
Velkova A, Diaz J, Pangilinan F, et al. The FUT2 secretor variant p.Trp154Ter influences serum vitamin B12 concentration via holo-haptocorrin, but not holo-transcobalamin, and is associated with haptocorrin glycosylation[J]. Hum Mol Genet, 2017, 26(24): 4975-4988.
|
| [6] |
Waxman S, Liu CK, Schreiber C, et al. The clinical and physiological implications of hepatoma B12-binding proteins[J]. Cancer Res, 1977, 37(6): 1908-1914.
|
| [7] |
Gick GG, Arora K, Sequeira JM, et al. Cellular uptake of vitamin B12: role and fate of TCblR/CD320, the transcobalamin receptor[J]. Exp Cell Res, 2020, 396(1): 112256.
|
| [8] |
Lin XH, Li DP, Liu ZY, et al. Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: A bioinformatics analysis and experimental validation[J]. Cancer Cell Int, 2023, 23(1): 52.
|
| [9] |
Simonsen K, Rode A, Nicoll A, et al. Vitamin B12 and its binding proteins in hepatocellular carcinoma and chronic liver diseases[J]. Scand J Gastroenterol, 2014, 49(9): 1096-1102.
|
| [10] |
Zhu X, Zhou G, Ma M, et al. Clinicopathological analysis and prognostic assessment of TCN1 in patients with gastric cancer[J]. Surg Innov, 2022, 29(5): 557-565.
|
| [11] |
Zhao L, Wei Y, Song A, et al. Association study between genome-wide significant variants of vitamin B12 metabolism and gastric cancer in a Han Chinese population[J]. IUBMB Life, 2016, 68(4): 303-310.
|
| [12] |
Lin DL, Wang LL, Zhao P, et al. Gastrointestinal goblet cell adenocarcinomas harbor distinctive clinicopathological, immune, and genomic landscape[J]. Front Oncol, 2021, 11: 758643.
|
| [13] |
Guo W, Deng L, Chen Z, et al. Vitamin B12-conjugated sericin micelles for targeting CD320-overexpressed gastric cancer and reversing drug resistance[J]. Nanomedicine (Lond), 2019, 14(3): 353-370.
|
| [14] |
Deng M, Ran P, Chen L, et al. Proteogenomic characterization of cholangiocarcinoma[J]. Hepatology, 2023, 77(2): 411-429.
|
| [15] |
Zhang H, Dong S, Feng J. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer[J]. J Cell Biochem, 2019, 120(6): 10767-10776.
|
| [16] |
Zhu X, Yi K, Hou D, et al. Clinicopathological analysis and prognostic assessment of transcobalamin Ⅰ (TCN1) in patients with colorectal tumors[J]. Med Sci Monit, 2020, 26: e923828.
|
| [17] |
Zhu X, Jiang X, Zhang Q, et al. TCN1 deficiency inhibits the malignancy of colorectal cancer cells by regulating the ITGB4 pathway[J]. Gut Liver, 2023, 17(3): 412-429.
|
| [18] |
Ruan S, Lin M, Zhu Y, et al. Integrin β4-targeted cancer immunotherapies inhibit tumor growth and decrease metastasis[J]. Cancer Res, 2020, 80(4): 771-783.
|
| [19] |
Wu Y, Wei J, Ming Y, et al. Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma[J]. J Cell Biochem, 2018, 119(9): 7696-7706.
|
| [20] |
吴艳. 胰腺导管内乳头状粘液性肿瘤（IPMN）的分子和免疫组化特性及TCN1在胰腺导管腺癌（PDAC）中的作用[D]. 北京：北京协和医学院, 2018.
|
| [21] |
Li H, Guo L, Cai Z. TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma[J]. World J Surg Oncol, 2022, 20(1): 83.
|
| [22] |
Waibel R, Treichler H, Schaefer NG, et al. New derivatives of vitamin B12 show preferential targeting of tumors[J]. Cancer Res, 2008, 68(8): 2904-2911.
|
| [23] |
Wuerges J, Geremia S, Randaccio L. Structural study on ligand specificity of human vitamin B12 transporters[J]. Biochem J, 2007, 403(3): 431-440.
|
| [24] |
Sah BR, Schibli R, Waibel R, et al. Tumor imaging in patients with advanced tumors using a new (99m) Tc-radiolabeled vitamin B12 derivative[J]. J Nucl Med, 2014, 55(1): 43-49.
|